[
    [
        {
            "time": "2023-11-01",
            "original_text": "公告精选丨蚂蚁集团中签号出炉；傲农生物10月生猪销售量同比增逾4倍",
            "features": {
                "keywords": [
                    "蚂蚁集团",
                    "中签号",
                    "傲农生物",
                    "生猪销售",
                    "同比增长"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "科技",
                    "农业"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "公告精选丨蚂蚁集团中签号出炉；傲农生物10月生猪销售量同比增逾4倍",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-11-01",
            "original_text": "复星集团郭广昌：制造业是温州的基础 创新应成为未来发展核心",
            "features": {
                "keywords": [
                    "复星集团",
                    "郭广昌",
                    "制造业",
                    "创新"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "制造业"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "复星集团郭广昌：制造业是温州的基础 创新应成为未来发展核心",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 6,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-11-01",
            "original_text": "莎普爱思滴眼液，因一致性评价问题或将停产；国采第三批陆续执行；77药品纳入临床急需境外新药名单｜云端周报 经营问题",
            "features": {
                "keywords": [
                    "莎普爱思",
                    "一致性评价",
                    "停产",
                    "国采",
                    "临床急需",
                    "境外新药"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "莎普爱思滴眼液，因一致性评价问题或将停产；国采第三批陆续执行；77药品纳入临床急需境外新药名单｜云端周报 经营问题",
                "Correlation": 8,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-11-01",
            "original_text": "复星医药(600196.SH)：就与Lilly签署许可协议现对主要付款安排作补充",
            "features": {
                "keywords": [
                    "复星医药",
                    "Lilly",
                    "许可协议",
                    "付款安排"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复星医药(600196.SH)：就与Lilly签署许可协议现对主要付款安排作补充",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-11-01",
            "original_text": "128股获买入评级最新: 中航机电",
            "features": {
                "keywords": [
                    "买入评级",
                    "中航机电"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "航空制造"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "128股获买入评级最新: 中航机电",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-11-01",
            "original_text": "复星医药：控股子公司复创医药与Lilly签署许可协议",
            "features": {
                "keywords": [
                    "复星医药",
                    "复创医药",
                    "Lilly",
                    "许可协议"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复星医药：控股子公司复创医药与Lilly签署许可协议",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 10
            }
        },
        {
            "time": "2023-11-01",
            "original_text": "医药生物行业专题研究：从壁垒出发寻找医美领域的确定性机遇",
            "features": {
                "keywords": [
                    "医药生物",
                    "医美",
                    "壁垒",
                    "机遇"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "医美"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "医药生物行业专题研究：从壁垒出发寻找医美领域的确定性机遇",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-11-01",
            "original_text": "医药行业每周药闻：医药零售板块2020年三季报业绩总结：抓住景气度提升明确的优质赛道",
            "features": {
                "keywords": [
                    "医药零售",
                    "三季报",
                    "业绩总结",
                    "景气度提升"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药零售"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药行业每周药闻：医药零售板块2020年三季报业绩总结：抓住景气度提升明确的优质赛道",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2023-11-01",
            "original_text": "热门融资标的股票分析",
            "features": {
                "keywords": [
                    "融资",
                    "标的股票",
                    "分析"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "热门融资标的股票分析",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-11-01",
            "original_text": "复星医药(600196)：业绩符合预期 创新药物成功出海！",
            "features": {
                "keywords": [
                    "复星医药",
                    "业绩",
                    "创新药物",
                    "出海"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复星医药(600196)：业绩符合预期 创新药物成功出海！",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 10
            }
        }
    ]
]